​​The Cambridge Crystallographic Data Centre (CCDC).
The CCDC websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them, see our cookie policy.

  • Deposit Structures
  • Access Structures
  • Contact Us
Register
Sign In
The Cambridge Crystallographic Data Centre (CCDC)
The Cambridge Crystallographic Data Centre (CCDC)
  • Sign In
  • Register
  • Community
    • Community
    • Blog
    • Deposit a Structure
    • Access Structures
    • CSD-Community
    • International Year of the Periodic Table
    • Awards and Sponsorship
    • FAIRE Programme
    • ​Collaborators and Partnerships
    • Initiatives
    • Training and Educational Resources
    • CSD Communications
  • Research & Consultancy
    • Research & Consultancy
    • CCDC Research
    • Consultancy & Partnerships
    • FAIR Data Principles
    • Posters
  • Solutions
    • Solutions
    • Data
    • Software
    • Services and Consultancy
    • Case Studies: our tools in action
    • CSD: The Cambridge Structural Database
    • For Academia
    • For Industry
    • What's new
    • Testimonials
  • News & Events
    • News & Events
    • News
    • Events
    • Newsletter
    • CSD 1 Million
    • Webinars
  • Support & Resources
    • Support & Resources
    • CSDS Downloads
    • Whitepapers
    • Hosted Services
    • Documentation and Resources
    • FAQs
    • Licence Portal
    • Downloads
  • About Us
    • About Us
    • Our History
    • Our Values
    • Management
    • Legal Status
    • Affiliates (NACs)
    • CSD Champions
    • Careers
    • Mindful Employer
    • Contact Us
  • Home
  • Community
  • Blog
  • Drug development

Blog Drug development

  1. Mogul in Action: Protein-ligand complex analysis to identify unusual torsional geometry in drug candidates

    Vera Prytkova – Wed, 14 Jul 2021 21:06:00 GMT

    Here we highlight a paper by John W. Liebeschuetz from Astex Pharmaceuticals that used Mogul to analyze the geometry of drug-like ligand models for high-resolution crystallographic protein-ligand complexes. This is part of our series highlighting examples of​​ the Cambridge Crystallographic Data Centre (CCDC) tools in action by scientists around the world.

    Continue reading…

  2. Getting the most from CSD-Materials

    Jeff Lengyel – Fri, 18 Jun 2021 20:20:00 GMT

    I’m a Research and Applications Scientist on the Materials Science team at CCDC. In this short blog and accompanying video, I walk through how to make the most of your CSD-Enterprise licence using the tools in CSD-Materials. In the first half of the video, I focus on the Cambridge Structural Database (CSD), highlighting its integrations with other databases and how to best use it for geometric analysis. In the second half of the video, I discuss applications of the CSD-Materials software, demonstrating how the different tools within the suite can help with pharmaceutical risk analysis.

    Continue reading…

  3. Learnings from our Discovery Science Conference: High-performance data meets high-performance computing

    Susan Reutzel-Edens – Thu, 17 Jun 2021 22:32:00 GMT

    We recently hosted our 2021 Discovery Science Conference: High-performance data meets high-performance computing. Over the course of the two-day event, leading researchers discussed how drug discovery continues to evolve – with data-driven approaches answering more questions than ever about novel and improved active pharmaceutical ingredients (APIs). Here are some of our key takeaways.

    Continue reading…

  4. CSD-CrossMiner in action: Identifying a target protein for new pharmaceuticals via scaffold search

    Francesca Stanzione – Fri, 28 May 2021 20:23:00 GMT

    Here we highlight a recent paper in which CSD-CrossMiner was used to find potential target protein(s) for newly synthesized spirobarbituric scaffolds. Such compounds have promising biomedical applications as anticonvulsants, anti-AIDS agents and anti-inflammatory remedies.

    This is part of our series highlighting examples of​​ the Cambridge Crystallographic Data Centre (CCDC) tools in action by scientists around the world.

    Continue reading…

  5. CSD-Discovery in action: identifying aldose reductase inhibitors from Green Fluorescent Protein (GFP) to treat diabetes complications

    Vera Prytkova – Fri, 14 May 2021 22:25:00 GMT

    Here we highlight a paper using CSD-Discovery to identify drug models for the treatment of complications due to diabetes and to define molecular features that can guide future drug design. This is part of our series highlighting examples of​​ the Cambridge Crystallographic Data Centre (CCDC) tools in action by scientists around the world.

    Continue reading…

  6. Using the Hydrogen Bond Propensity (HBP) tool to identify polymorphs

    Ioana Sovago – Tue, 11 May 2021 16:29:00 GMT

    The existence of various molecular arrangements that occur in the solid-state is called polymorphism. Identifying polymorphs is important for risk management purposes and exploring the polymorphic landscape to identify the most stable forms is an important step during early-stage drug development. As part of our Tools in Action blog series highlighting the use of CCDC tools by scientists around the world, we recently showed how a research team used the Cambridge Structural Database (CSD) and the Hydrogen Bond Propensity (HBP) tool to characterize two polymorphs of an anti-inflammatory drug and predict the existence of additional forms. Here we present more information about how the HBP tool works to see if you can use it to assess polymorphs.

    Continue reading…

  7. CSD Ligand Overlay in action: ligand-based drug design of competitive inhibitors against DAHPS and EPSPS

    Vera Prytkova – Tue, 04 May 2021 14:24:00 GMT

    Here we highlight a paper using the CSD Ligand Overlay tool in ligand-based drug design for the development of antibiotics and antifungals. This is part of our series highlighting examples of​​ the Cambridge Crystallographic Data Centre (CCDC) tools in action by scientists around the world.

    Continue reading…

  8. How can the CSD Ligand Overlay program assist with ligand-based drug design?

    Vera Prytkova – Wed, 28 Apr 2021 22:30:00 GMT

    How do you design a drug if you don't know the target protein structure? Ligand-based drug design is an approach used in the absence of 3D structures of drug targets. This enables early-stage discovery and lead optimisation even when the protein structure is unknown. One option involves pharmacophore modelling, and it can be used in lieu of a protein-structure-based pathway.

    Continue reading…

  9. CSD in action: analysis of the metastable polymorph of Loratadine

    Suzanna Ward – Tue, 16 Feb 2021 12:49:00 GMT

    Here we spotlight a recent publication which shows how CSD data supported a team from Novartis and NanoMEGAS to analyse a metastable form of the antihistamine drug Loratadine. Part of our series highlighting examples of our data and software in use around the world.

    Continue reading…

  • ‹ Newer
  • Older ›

Search Blogs

  • This blog
  • All blogs
Search

Topics

agriculture 3 agrochemical 3 AI 5 Aromatics Analyser 4 British Crystallographic Association 1 CCDC 1 Chemical Crystallography Group 1 cheminformatics 5 community 2 Computational chemistry 6 Conformation 6 ConQuest 2 COVID-19 12 Crystal Conversations 3 Crystal engineers 2 crystal structure prediction 7 crystalline rugosity 1 Crystallographers 6 Crystallography 11 CSD 73 CSD 3D Print 2 CSD Communications 19 CSD Conformer Generator 4 CSD database 3 CSD Educators 15 CSD Ligand Overlay 3 CSD Ligand Screener 1 CSD Linker Database 1 CSD Python API 9 CSD Sketcher 3 CSD Subsets 4 CSD System 41 CSD-Community 3 CSD-Core 18 CSD-CrossMiner 5 CSD-Discovery 9 CSD-Enterprise 8 CSD-Materials 18 CSD-Theory 2 CSP Blind Test 13 data 9 Data mining 12 Data Revolution 2 Data Update 5 database 12 Database Evolution 1 Database Group 27 Docking 5 Drug development 19 Drug Discovery 29 dynamic disorder 1 Education and Outreach 18 Energy Industry 1 environmental science 1 Events 17 FDA 2 fragment based drug design 2 GOLD 6 Healthcheck 2 history 3 hydrogenbond 1 IsoStar 1 IUCr 3 KNIME 1 Licensing 2 machine learning 3 Mercury 11 Metal Organic Frameworks 7 Mogul 3 molecular complementarity tool 3 News 2 Olga Kennard 1 organic crystallography 2 organometallic complexes 3 organometallic ligands 3 Our tools in action 18 our values 1 partnerships 1 People 7 pharmaceutical 2 pharmaceutical discovery 13 pharmaceuticals 9 Pharmacophore 5 Pipeline Pilot 1 polymorph 10 Poster 1 Protein Data Bank 2 protein prediction 1 Release 2020.1 4 Release 2020.2 3 Release 2021.1 3 Release 2021.2 2 Release 2021.3 5 science communication 1 Science Stories 10 Scientific research 6 semiconductors 2 SMARTS 1 Smiles 3 software 1 solid form informatics 2 Struchkov Prize 1 Summer Data Sharing 1 SuperStar 3 UGM 6 Virtual Screening 2 WebCSD 19 Website 3 Women in Science 1 Workshop 3

Archive

May 2022 3 April 2022 2 March 2022 2 February 2022 1 January 2022 4 December 2021 9 November 2021 4 October 2021 4 September 2021 7 August 2021 9 July 2021 9 June 2021 10 May 2021 9 April 2021 7 March 2021 8 February 2021 11 January 2021 5 December 2020 6 November 2020 5 October 2020 6 September 2020 9 August 2020 6 July 2020 3 June 2020 4 May 2020 2 April 2020 9 March 2020 6 February 2020 6 January 2020 2 December 2019 4 November 2019 10 October 2019 6 September 2019 2 June 2019 3 May 2019 1 April 2019 2 March 2019 7 February 2019 3 December 2018 1 November 2018 2 October 2018 2 August 2018 2 June 2018 3 May 2018 1 March 2018 1 February 2018 2 December 2017 1 October 2017 3 June 2017 1 May 2017 1 April 2017 1 March 2017 3 February 2017 1 December 2016 1 November 2016 2 October 2016 3 July 2016 2 June 2016 1 March 2016 1 February 2016 1 December 2015 1 November 2015 2 October 2015 1 September 2015 1 August 2015 2 July 2015 2 June 2015 2 February 2015 1 December 2014 5 November 2014 1 October 2014 1 September 2014 1 August 2014 1 July 2014 1 June 2014 2 April 2014 2 January 2014 3 October 2013 1 September 2013 1 July 2013 1 June 2013 1 April 2013 2 March 2013 3 January 2013 2 December 2012 4 November 2012 2 October 2012 3 September 2012 1 August 2012 1 July 2012 1 June 2012 1 May 2012 2 March 2012 1 February 2012 2
  • Home
  • Deposit Structures
  • Access Structures
  • CCDC Policies
  • The CCDC

Terms of UsePrivacy Policy

  • Link to Linkedin
  • Link to Youtube
  • Link to Twitter
  • Link to Facebook
  • Follow CCDC: